Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: kathleen who wrote (48)	4/24/1998 9:16:00 PM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

Immucor Canada? MonoGen Inc. Teams with Immucor Canada Inc. to Distribute Monolayer Slide Preparation System HERNDON, Va.--(BW HealthWire)--April 24, 1998--MonoGen Inc. Friday reported it has entered into an agreement with Immucor(R) Canada Inc. to distribute the MonoPrep2(tm), a liquid-based monolayer slide preparation system, throughout Canada. Kevin Blackburn, vice president of sales and marketing for Immucor(R) Canada, said Immucor(R) is dedicated to the delivery of innovative, value-added products and exceptional customer service. "Immucor(R) Canada focuses on specialized niches within the clinical diagnostic lab," said Blackburn. "Because we are very active in cytology and histology within the hospital, private laboratory testing, and clinical research markets, MonoPrep2(tm) is particularly appealing to us. We anticipate the system will be well received, not only because it is applicable to these markets, but also because it's affordable. We look forward to launching its distribution." Peter Kilner, vice president of marketing and sales for MonoGen Inc., said, "Immucor(R) Canada has worked hard to establish its reputation as a company which partners with manufacturers of top-end products. They have certainly demonstrated their effectiveness with other histology and cytology products they distribute, and we are confident they will provide the service and expertise that we wish to offer MonoPrep2(tm) users." Ghassan Serhan, international sales manager for MonoGen Inc., said, "The agreement with Immucor(R) Canada is an exceptional opportunity for MonoGen to expand and strengthen its international distribution network, as Immucor(R) has a significant market position in anatomical pathology in Canada." MonoGen Inc., headquartered in Herndon, develops products and services for the early detection, screening and diagnosis of cancer and other diseases. Immucor(R) Canada Inc. is based in Edmonton, Alberta. To edit your profile, go to keyword NewsProfiles. For all of today's news, go to keyword News